AI assistant
INTUITIVE SURGICAL INC — Director's Dealing 2021
Apr 28, 2021
29809_dirs_2021-04-27_e0833f93-b874-4201-aea6-b737d4b09f7b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INTUITIVE SURGICAL INC (ISRG)
CIK: 0001035267
Period of Report: 2021-04-26
Reporting Person: MOHR MARSHALL (Executive VP & CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-04-26 | Common Stock | M | 9375 | $153.0467 | Acquired | 9375 | Direct |
| 2021-04-26 | Common Stock | S | 9375 | $865.6341 | Disposed | 0 | Direct |
| 2021-04-26 | Common Stock | M | 21000 | $172.4367 | Acquired | 21000 | Direct |
| 2021-04-26 | Common Stock | S | 12588 | $865.7374 | Disposed | 8412 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-04-26 | Non-Qualified Stock Option (right to buy) | $153.0467 | M | 9375 | Disposed | 2024-08-15 | Common Stock (9375) | Direct |
| 2021-04-26 | Non-Qualified Stock Option (right to buy) | $172.4367 | M | 21000 | Disposed | 2022-08-15 | Common Stock (21000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 23492 | Indirect |
Footnotes
F1: These shares were exercised and sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 2, 2021.
F2: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $860.174 to $870.00,inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $861.74 to $870.046,inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F4: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.